- Home
- JAGX vs EZPW Comparison
JAGX vs EZPW Comparison
Compare JAGX & EZPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- EZPW
- Stock Information
- Founded
- JAGX 2013
- EZPW 1989
- Country
- JAGX United States
- EZPW United States
- Employees
- JAGX 49
- EZPW N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- EZPW Other Specialty Stores
- Sector
- JAGX Health Care
- EZPW Consumer Discretionary
- Exchange
- JAGX Nasdaq
- EZPW Nasdaq
- Market Cap
- JAGX 3.1M
- EZPW N/A
- IPO Year
- JAGX N/A
- EZPW 1991
- Fundamental
- Price
- JAGX $4.85
- EZPW $15.52
- Analyst Decision
- JAGX
- EZPW Strong Buy
- Analyst Count
- JAGX 0
- EZPW 3
- Target Price
- JAGX N/A
- EZPW $17.17
- AVG Volume (30 Days)
- JAGX 37.8K
- EZPW 834.7K
- Earning Date
- JAGX 03-31-2025
- EZPW 04-30-2025
- Dividend Yield
- JAGX N/A
- EZPW N/A
- EPS Growth
- JAGX N/A
- EZPW 77.06
- EPS
- JAGX N/A
- EZPW 1.14
- Revenue
- JAGX $11,689,000.00
- EZPW $1,181,781,000.00
- Revenue This Year
- JAGX $18.18
- EZPW $9.42
- Revenue Next Year
- JAGX $40.06
- EZPW $6.85
- P/E Ratio
- JAGX N/A
- EZPW $13.60
- Revenue Growth
- JAGX 19.75
- EZPW 8.95
- 52 Week Low
- JAGX $4.41
- EZPW $9.65
- 52 Week High
- JAGX $540.00
- EZPW $16.35
- Technical
- Relative Strength Index (RSI)
- JAGX 20.48
- EZPW 67.93
- Support Level
- JAGX $4.41
- EZPW $14.10
- Resistance Level
- JAGX $5.45
- EZPW $15.35
- Average True Range (ATR)
- JAGX 0.95
- EZPW 0.48
- MACD
- JAGX 0.00
- EZPW 0.08
- Stochastic Oscillator
- JAGX 3.54
- EZPW 86.43
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.